Marketing analysis of the market of antibacterial drugs for treatment of acute simple bronchitis in infants
Journal Title: Фармацевтичний журнал - Year 2016, Vol 5, Issue 5
Abstract
Particular concern among pediatricians and health professionals is caused by fairly high levels of morbidity acute simple bronchitis, especially in infants. An important issue of the pharmacotherapy is ensuring patients of sufficient number of effective and affordable drugs for the treatment of this nosology. Therefore, the aim of the work was the study of the assortment of antibacterial drugs for the treatment of acute simple bronchitis in children up to 3 years in the pharmaceutical market of Ukraine. Analytical, comparative, marketing, graphical methods of analysis, and the method of descriptive and abstract modeling and synthesis were used in the study. The analysis of the State Register of medicines, according to which established that as of May 2016 in the market of Ukraine registered 237 trade names of antibacterial drugs for the treatment of acute bronchitis in children, was conducted. Among them, the largest share falls on subgroups’ drugs of ceftriaxone (27.43%), cefuroxime (18.14%), ceftazidime (10.97%) and cefotaxime (10.13%). Results of the analysis show that the domestic market of antibacterial drugs is fairly saturated mainly due to foreign-made drugs, whose share in the overall structure of the investigated range is nearly 70.00%. It was found that the antibacterial drugs was introduced in the market by 23 producing countries, and the leading are drugs the production of India, which are presented in 7 subgroups of the general number of 52 names, and Ukraine are represented in the 10 subgroups in the amount of 72 names. The analysis found that the antibacterial drugs are present in the Ukrainian market by four dosage forms among which are leading parenteral release form. However, a significant number of drugs, particularly subgroups cefoperazone, ceftriaxone, ceftazidime, cefotaxime, cefazolin have no analogs in the available children's dosage forms, which negatively affects the effectiveness of treatment of such patients.
Authors and Affiliations
A. A. Kotvitska, E. S. Korobova
Keywords
Related Articles
- EP ID EP565569
- DOI -
- Views 54
- Downloads 0
In silico screening of drug-like molecules for the treatment of cardiovascular diseases on the basis of five-membered privileged heterocycles
Among various heterocyclic systems, the derivatives of five-membered heterocycles are of special interest. Most of the above mentioned heterocycles are treatred as so-called privileged structures in modern medicinal chem...
Research of acute toxicity of the drug HEXIA
Diseases of the genitourinary system caused by pathogenic and potentially pathogenic microorganisms, which result into disbiosis of urinary organs, remain an urgent problem of dermatovenereology, gynecology and urology,...
Justification of technology of extemporaneous suppositories for prostatitis treatment based on the medicine «Trezivit-prost»
Chronic abacterial prostatitis is one of the most common diseases among the male population, both in Ukraine and abroad. Pharmaceutical compounding in conditions of the pharmacy allows individual selection of active subs...
Pharmaseutical development of polyion solutios for infusions. justification of presence of active pharmeceutical ingridients and additions
Modern manufacturing of any pharmaceutical treatment is impossible without a precise scrutiny of all factors that may influence on quality of end-product. As well quality has to be taken into account while developing thi...
Study of compatibility of filter materials with solution of meloksmkama for injections
One of pharmaceutical design of parenterally solutions times is establishment of influence of filter materials on quality of preparation and choice of optimum filter membranes on the basis of these researches, establishm...